-
The emergence of maternal DNA testing for fetal an-euploidies has necessitated a rethinking of our standard screening protocols. With reasonable accuracy, a single blood test can now rule out fetal trisomy 21, 18, and 13, in addition to sex chromosome abnormalities such as Turner syndrome.
-
Between September 1, 1987, and January 31, 2001, a total of 4047 obese persons were enrolled in the Swedish Obesity Study (SOS) intervention trial.
-
Mediators of the autonomic response to stress, such as the catecholamines norepinephrine and epinephrine, promote cancer growth, metastasis, and progression in preclinical models.
-
Although the incidence of hysterectomy has declined in recent years, it remains the most common major gynecologic procedure, and many women are offered or consider elective bilateral oophorectomy (BSO) at the time of hysterectomy to reduce ovarian cancer risk.
-
In this issue: Dementia and benzodiazepines; effectiveness of omega-3 fatty acid and Ginkgo biloba supplements; and FDA actions.
-
In discussing birth control options with a patient, she tells you she is interested in taking the Pill, but is concerned that it might be dangerous due to all the risks. Whats your next move?
-
Get ready to add new information to your contraceptive clinical dataset.
-
Unscheduled spotting and bleeding occurs in 30% to 50% of women in the first few months of combined oral contraceptive (OC) use.1 How can you help patients stay the course?
-
One of the clearest outcomes of the 2012 election is that the Affordable Care Act (ACA), better known as Obamacare, has survived the last major threat to its existence.
-
An annual Pap smear might soon become a thing of the past. Most women should be screened for cervical cancer no more often than once every three to five years, according to new cervical cancer screening guidance issued by the American College of Obstetricians and Gynecologists (ACOG).